Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

09. September 2021 09:00 ET | Quelle: CMI

Global Chronic Aspergillosis Treatment Market to Surpass US$ 4,056.4 Million by 2028, Says Coherent Market Insights (CMI)

SEATTLE, Sept. 09, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global chronic aspergillosis treatment market is estimated to be valued at US$ 2,916.3 million in 2021 and is...
27. Mai 2021 07:00 ET | Quelle: Pulmocide

Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945

Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945 London, UK, 27 May 2021 – Pulmocide Ltd., (“the Company”) a late-stage biopharmaceutical company...
27. Mai 2021 02:00 ET | Quelle: Jeito Capital

Jeito Capital leads oversubscribed $92 million Series C financing round in Pulmocide

Jeito Capital leads oversubscribed $92 million Series C financing round in Pulmocide Jeito selects Pulmocide as its fourth investment since launching the fundPulmocide is a late-stage biopharma...
27. Mai 2021 02:00 ET | Quelle: Pulmocide

Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945

Pulmocide Raises $92 million in a Series C Financing to Fund Registration Program for PC945 London, UK, 27 May 2021 – Pulmocide Ltd., (“the Company”) a late-stage biopharmaceutical company...